PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma

Haematologica. 2006 Dec;91(12 Suppl):ECR54.

Authors

Lionel Karlin¹, Emmanuel Itti, Cécile Pautas, Mohamed Rachid, Dominique Bories, Catherine Cordonnier, Sébastien Maury

Affiliation

¹ Department of Hematology, Hôpital Henri Mondor, 94010 Créteil cedex, France.

PMID: 17194660

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Biomarkers, Tumor / analysis
Biomarkers, Tumor / genetics
Bone Marrow Transplantation
Combined Modality Therapy
Cytarabine / administration & dosage
Duodenal Neoplasms / diagnostic imaging*
Duodenal Neoplasms / drug therapy
Duodenal Neoplasms / genetics
Duodenal Neoplasms / surgery
Early Diagnosis
Humans
Leukemic Infiltration / drug therapy
Male
Meninges / pathology
Neoplasm Recurrence, Local / diagnostic imaging*
Neoplasm Recurrence, Local / drug therapy
Oncogene Proteins, Fusion / analysis
Oncogene Proteins, Fusion / genetics
Positron-Emission Tomography*
Remission Induction
Sarcoma, Myeloid / diagnostic imaging*
Sarcoma, Myeloid / drug therapy
Sarcoma, Myeloid / genetics
Sarcoma, Myeloid / surgery
Transplantation, Homologous

Substances

Biomarkers, Tumor
CBFbeta-MYH11 fusion protein
Oncogene Proteins, Fusion
Cytarabine